Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AMRS

Amyris (AMRS)

Amyris Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMRS
DataHoraFonteTítuloCódigoCompanhia
23/04/202417:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRSAmyris Inc
02/04/202407:06Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:AMRSAmyris Inc
05/01/202418:22Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AMRSAmyris Inc
17/08/202320:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AMRSAmyris Inc
14/08/202308:15IH Market NewsMonday’s Wall Street Highlights: US Steel, Tesla, Nikola, AMC Entertainment, and moreNASDAQ:AMRSAmyris Inc
11/08/202323:32KR Market News소매 투자자들이 페니 주식에 집중: 위워크, 아미리스NASDAQ:AMRSAmyris Inc
10/08/202309:34Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:AMRSAmyris Inc
10/08/202308:12IH Market NewsThursday’s Wall Street Highlights: Capri Holdings, Disney, Sonos, Applovin, Plug Power, and moreNASDAQ:AMRSAmyris Inc
10/08/202300:20KR Market News생명공학 회사 아미리스, 미국에서 파산 신청NASDAQ:AMRSAmyris Inc
09/08/202322:38PR Newswire (US)AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATIONNASDAQ:AMRSAmyris Inc
29/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMRSAmyris Inc
26/06/202310:10PR Newswire (US)AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCENASDAQ:AMRSAmyris Inc
09/06/202317:15Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AMRSAmyris Inc
05/06/202309:37PR Newswire (US)AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDINGNASDAQ:AMRSAmyris Inc
19/05/202309:00PR Newswire (US)AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENENASDAQ:AMRSAmyris Inc
09/05/202317:05PR Newswire (US)AMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTSNASDAQ:AMRSAmyris Inc
02/05/202309:00PR Newswire (US)AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9NASDAQ:AMRSAmyris Inc
25/04/202307:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AMRSAmyris Inc
24/04/202309:59PR Newswire (US)AMYRIS REPORTS Q1 2023 REVENUENASDAQ:AMRSAmyris Inc
21/04/202319:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMRSAmyris Inc
11/04/202317:37Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMRSAmyris Inc
11/04/202317:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMRSAmyris Inc
06/04/202319:35Edgar (US Regulatory)Amended Report of Proposed Sale of Securities (144/a)NASDAQ:AMRSAmyris Inc
05/04/202309:00PR Newswire (US)AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDANNASDAQ:AMRSAmyris Inc
31/03/202317:35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AMRSAmyris Inc
17/03/202307:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMRSAmyris Inc
15/03/202317:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:AMRSAmyris Inc
15/03/202317:11PR Newswire (US)AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTSNASDAQ:AMRSAmyris Inc
28/02/202310:00PR Newswire (US)AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 15, 2023NASDAQ:AMRSAmyris Inc
22/02/202308:00PR Newswire (US)GIVAUDAN TO ACQUIRE PORTFOLIO OF MAJOR COSMETIC INGREDIENTS FROM AMYRIS AND TO ESTABLISH STRATEGIC PARTNERSHIP FOR NATURAL, SUSTAINABLY SOURCED INGREDIENTS FOR THE BEAUTY INDUSTRYNASDAQ:AMRSAmyris Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMRS